JY
IMVT icon

Jeff Yass’s Immunovant IMVT Stock Holding History

Jeff Yass’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.05M Sell
183,000
-282,900
-61% -$8.62M ﹤0.01% 3977
2026
Q1 		$11.6M Buy
465,900
+298,600
+178% +$7.73M ﹤0.01% 2896
2025
Q4 		$4.25M Buy
167,300
+97,100
+138% +$2.17M ﹤0.01% 4281
2025
Q3 		$1.13M Sell
70,200
-24,300
-26% -$393K ﹤0.01% 7050
2025
Q2 		$1.51M Sell
94,500
-90,300
-49% -$1.37M ﹤0.01% 6422
2025
Q1 		$3.16M Buy
184,800
+85,700
+86% +$1.79M ﹤0.01% 4557
2024
Q4 		$2.45M Buy
99,100
+40,200
+68% +$1.14M ﹤0.01% 4854
2024
Q3 		$1.68M Buy
58,900
+17,300
+42% +$510K ﹤0.01% 5647
2024
Q2 		$1.1M Sell
41,600
-177,000
-81% -$5.03M ﹤0.01% 6356
2024
Q1 		$7.06M Sell
218,600
-7,900
-3% -$288K ﹤0.01% 3111
2023
Q4 		$9.54M Sell
226,500
-68,200
-23% -$2.51M ﹤0.01% 2696
2023
Q3 		$11.3M Buy
294,700
+133,500
+83% +$3.02M ﹤0.01% 2392
2023
Q2 		$3.06M Buy
161,200
+44,500
+38% +$830K ﹤0.01% 4336
2023
Q1 		$1.81M Buy
116,700
+11,500
+11% +$200K ﹤0.01% 5356
2022
Q4 		$1.87M Buy
105,200
+10,100
+11% +$127K ﹤0.01% 4833
2022
Q3 		$531K Sell
95,100
-19,400
-17% -$94.8K ﹤0.01% 8325
2022
Q2 		$447K Buy
114,500
+3,000
+3% +$13K ﹤0.01% 8557
2022
Q1 		$614K Sell
111,500
-83,000
-43% -$517K ﹤0.01% 8414
2021
Q4 		$1.66M Sell
194,500
-240,600
-55% -$1.99M ﹤0.01% 5966
2021
Q3 		$3.78M Buy
435,100
+237,700
+120% +$2.14M ﹤0.01% 4463
2021
Q2 		$2.09M Buy
197,400
+168,000
+571% +$2.35M ﹤0.01% 5823
2021
Q1 		$472K Buy
+29,400
New +$775K ﹤0.01% 9615

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's IMVT Position: Q2 2026 in Review

Jeff Yass increased its Immunovant (IMVT) stake by 66% in Q2 2026, buying an estimated $12.3M and bringing the position to 1,022,513 shares worth $39.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1756.

Jeff Yass first reported a position in IMVT in Q3 2020 and has held it in 24 quarters since. 225 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Jeff Yass held 1,022,513 shares of Immunovant worth $39.4M as of Q2 2026.
  • Jeff Yass bought 404,706 Immunovant shares in Q2 2026, an estimated $12.3M.
  • Immunovant made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #1756 holding.
  • Jeff Yass first reported a position in Immunovant in Q3 2020 and has held it in 24 quarters since.
  • 225 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.